Tenet Healthcare Corporation New vs Johnson & Johnson
THC vs JNJ — side-by-side comparison from reported financials. THC leads 4, JNJ leads 6 of 10 comparable metrics.
Tenet Healthcare Corporation New
THC · Healthcare
$264.31+1.44%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | THC | JNJ |
|---|---|---|
| Price | $264.31 | $261.79 |
| Market cap | $21.3B | $631B |
| Revenue (TTM) | $21.8B | $97.9B |
| Revenue growth | +3.6% | +5.6% |
| Net margin | 10.3% | 21.5% |
| Free cash flow | $3.02B | $22.2B |
| Net cash (debt) | ($10.3B) | ($27.8B) |
| 1-year price return | +35.6% | +37.0% |
| P/E | 9.5 | 29.9 |
| P/E vs own history (cheap-side %) | 50% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 51% | 26% |
| Altman Z-score | 1.51 | — |
| CV checks passed | 9 of 10 | 10 of 10 |
| Employees | 99,000 | 140,800 |
Full résumé-style profiles: THC CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.